|
Federal
Register Notices > Notices of
Application - 2000
> Sigma Aldrich Research Biochemicals, Inc.
[Federal Register: June 2, 2000 (Volume 65, Number
107)]
[Notices]
[Page 35397]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02jn00-99]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of
Application
Pursuant to Section 1301.33(a) of Title 21 of the
Code of Federal Regulations (CFR), this is notice that on April 14,
2000, Sigma Aldrich Research Biochemicals, Inc., Attn: Richard Milius,
1-3 Strathmore Road, Natick, Massachusetts 01760, made application by
renewal to the Drug Enforcement Administration (DEA) for registration as
a bulk manufacturer of the basic classes of controlled substances listed
below:
| Drug |
Schedule |
| Cathinone (1235) |
I |
| Methcathinone (1237) |
I |
| Aminorex (1585) |
I |
| Alpha-Ethyltryptamine (7249) |
I |
| Lysergic acid diethylamide
(7315) |
I |
| Tetrahydrocannabinols (7370) |
I |
| 4-Bromo-2,
5-dimethoxyamphetamine (7391) |
I |
| 4-Bromo-2,
5-dimethoxyphenethylamine (7392) |
I |
| 2,5-Dimethoxyamphetamine (7396) |
I |
| 3,4-Methylenedioxyamphetamine
(7400) |
I |
| N-Hydroxy-3,
4-methylenedioxyamphetamine (7402) |
I |
| 3,
4-Methylenedioxy-N-ethylamphetamine (7404) |
I |
| 3,
4-Methylenedioxymethamphetamine (7405) |
I |
| Psilocybin (7437) |
I |
| 1-[1-(2-Thienyl) cyclohexyl]
piperidine (7470) |
I |
| Heroin (9200) |
I |
| Normorphine (9313) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Pentobarbital (2270) |
II |
| Phenylcyclohexylamine (7460) |
II |
| Phencyclidine (7471) |
II |
|
Cocaine (9041) |
II |
|
Codeine (9050) |
II |
|
Diprenorphine (9058) |
II |
|
Benzoylecgonine (9180) |
II |
|
Levomethorphan (9210) |
II |
|
Levorphanol (9220) |
II |
|
Meperidine (9230) |
II |
|
Metazocine (9240) |
II |
|
Methadone (9250) |
II |
|
Morphine (9300) |
II |
|
Thebaine (9333) |
II |
|
Levo-alphacetylmethadol (LAAM) (9648) |
II |
|
Fentanyl (9801) |
II |
The firm plans to manufacture the listed
controlled substances for laboratory reference standards and neurochemicals.
Any other such applicant and any person who is presently registered with DEA to manfuacture such substance may file comments or objections
to the issuance of the proposed registration.
Any such comments or objections may be addressed, in
quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, United States Department of Justice, Washington, D.C. 20537, Attention: DEA Federal Register Representative
(CCR), and must be file no later than August 1, 2000.
Dated: May 12, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 00-13787 Filed 6-1-00; 8:45 am]
BILLING CODE 4410-09-M
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
Back to
Top
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|
